Clinical Watch helps Medicaid pharmacy programs understand pharmacy trends, uncover gaps in care and prepare for future needs. We provide monthly updates on pharmacy trends, criteria reviews and new medications
Explore our Clinical Watch NewsletterLearn More
Other content in this Stream
In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofi
Value purchasing for Medicaid programs
In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associated with COVID-19 treatment and suggest prior authorization criteria for the first approved tre
In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug.
To successfully reopen the U.S. economy, public health agencies must perform extensive contact tracing to keep new cases of the virus from growing into a larger outbreak.
The need for timely, accurate information-sharing among key healthcare stakeholders is crucial to preventing the spread of COVID-19.
Conduent's cloud-based COVID-19 module empowers public health authorities and private organizations with contact tracing to monitor, track, and report on confirmed COVID-19 cases along with those expo
In this issue of Clinical Watch, we discuss COVID-19 and suggest prior authorization criteria for immunotherapy to reduce the severity of allergic reactions to peanuts.
In this issue of Clinical Watch, we discuss the expanded indication for drugs to treat relapsing forms of multiple sclerosis.
Learn how community pharmacists can be an agents of change in the fight against substance abuse.